Study of the Effects of a Study Drug in Controlling Bladder Pain in Patients with Bladder Pain Syndrome/Interstitial Cystitis

What we are studying

The purpose of this research study is to determine whether the study drug is safe and effective in controlling bladder pain in patients with Bladder Pain Syndrome/Interstitial Cystitis. The study drug, URG101, is an experimental drug that is being tested to see what effects (good and bad) it has on you and your bladder pain.

Who we are studying

  • Women
  • Races:
    • White
    • African American
    • Asian
    • American Indian or Alaska Native
    • Native Hawaiian or Pacific Islander
    • Other
  • All Ethnicities
  • Ages 18+

Eligibility Criteria

  • Diagnosed with interstitial cystitis
  • Bladder pain for at least 9 months
  • No allergies to heparin or lidocaine

What is involved

  • One administration with study drug using a catheter
  • 2-3 visits to clinic depending on whether you can have treatment same day of the Screening visit; Vital signs
  • Physical exam (1)
  • Blood draws
  • Questionnaires
  • Follow up phone call (1)

Compensation

$25 for screening/treatment visit--(if screening and treatment are separate, there is still only one payment for both) $25 for follow up visit $25 for follow up phone call ($75 if all visits are completed)

Contact Information

Study Coordinator
Janet Shuping
Email
jshuping@wakehealth.edu
Phone
336-716-2612
Principal Investigator
Robert J. Evans, M.D.

Disclaimer: The information on this website is for general informational purposes only and SHOULD NOT be relied upon as a substitute for sound professional medical advice, evaluation or care from your physician or other qualified health care provider.